Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CSTB accelerates the progression of hepatocellular carcinoma via the ERK/AKT/mTOR signaling pathway

13 Dec 2023

Abstract excerpt

Hepatocellular carcinoma (HCC) is a significant contributor to global cancer-related deaths, leading to high mortality rates. However, the pathogenesis of HCC remains unclear. In this research, by the bioinformatics data analysis, we found that elevated CSTB expression correlated with advanced disease and predicted diminished overall survival (OS) in HCC patients. We subsequently verified the oncogenic role of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to FOXO transcription factor regulation
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38187282
DOI: 10.1016/j.heliyon.2023.e23506

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CSTB accelerates the progression of hepatocellular carcinoma via the ERK/AKT/mTOR signaling pathwayPMID 38187282Read ↗

Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells.Semantic proximity Read ↗

LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1Semantic proximity Read ↗

Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approachesSemantic proximity Read ↗

MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling PathwaySemantic proximity Read ↗

LACTB Regulates PIK3R3 to Promote Autophagy and Inhibit EMT and Proliferation Through the PI3K/AKT/mTOR Signaling Pathway in Colorectal CancerSemantic proximity Read ↗

Circular RNA Circ0021205 Promotes Cholangiocarcinoma Progression Through MiR-204-5p/RAB22A AxisSemantic proximity Read ↗

Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1Semantic proximity Read ↗

AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progressionSemantic proximity Read ↗

AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progressionSemantic proximity Read ↗

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathwaySemantic proximity Read ↗

Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in CholangiocarcinomaSemantic proximity Read ↗

CST6 promotes the aggressive phenotype of thyroid cancer through maintaining autophagySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.